by Ernie Mundell Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows. A wider study, published in June, found that retatrutide helped obese people lose about a quarter of their starting weight over an 11-month period. Now, findings from...
UNIVERSITÄT LEIPZIG Image: Anja Saalbach Credit: Photo: Leipzig University In everyday clinical practice, it has been observed that chronic inflammatory diseases like psoriasis occur earlier and more severely in overweight people. In addition, they are more difficult to treat in patients with obesity. Experts at Leipzig University Hospital therefore wanted to find out why chronic...
